154 related articles for article (PubMed ID: 34878159)
1. Analysis of differentially expressed long non‑coding RNAs revealed a pro‑tumor role of MIR205HG in cervical cancer.
Yin L; Zhang Y; Zheng L
Mol Med Rep; 2022 Feb; 25(2):. PubMed ID: 34878159
[TBL] [Abstract][Full Text] [Related]
2. Long non-coding RNA MIR205HG regulates KRT17 and tumor processes in cervical cancer via interaction with SRSF1.
Dong M; Dong Z; Zhu X; Zhang Y; Song L
Exp Mol Pathol; 2019 Dec; 111():104322. PubMed ID: 31655037
[TBL] [Abstract][Full Text] [Related]
3. Long non-coding RNA MIR205HG function as a ceRNA to accelerate tumor growth and progression via sponging miR-122-5p in cervical cancer.
Li Y; Wang H; Huang H
Biochem Biophys Res Commun; 2019 Jun; 514(1):78-85. PubMed ID: 31023531
[TBL] [Abstract][Full Text] [Related]
4. Reconstruction and analysis of the aberrant lncRNA-miRNA-mRNA network based on competitive endogenous RNA in CESC.
Song J; Ye A; Jiang E; Yin X; Chen Z; Bai G; Zhou Y; Liu J
J Cell Biochem; 2018 Aug; 119(8):6665-6673. PubMed ID: 29741786
[TBL] [Abstract][Full Text] [Related]
5. DGUOK-AS1 promotes cervical squamous cell carcinoma progression by suppressing miR-499a-5p that targets SPRR1B in vitro.
Song Y; Pan H; Yang L; Fan Y; Zhang H; Pan M; Zhang Y
Biochem Biophys Res Commun; 2021 Dec; 585():177-184. PubMed ID: 34808501
[TBL] [Abstract][Full Text] [Related]
6. Construction and Analysis of lncRNA-Mediated ceRNA Network in Cervical Squamous Cell Carcinoma by Weighted Gene Co-Expression Network Analysis.
Chen W; Chen X; Wang Y; Liu T; Liang Y; Xiao Y; Chen L
Med Sci Monit; 2019 Apr; 25():2609-2622. PubMed ID: 30965350
[TBL] [Abstract][Full Text] [Related]
7. MIR205HG acts as a ceRNA to expedite cell proliferation and progression in lung squamous cell carcinoma via targeting miR-299-3p/MAP3K2 axis.
Liu L; Li Y; Zhang R; Li C; Xiong J; Wei Y
BMC Pulm Med; 2020 Jun; 20(1):163. PubMed ID: 32513149
[TBL] [Abstract][Full Text] [Related]
8. LncRNA miR205HG hinders HNRNPA0 translation: anti-oncogenic effects in esophageal carcinoma.
Dong X; Chen X; Lu D; Diao D; Liu X; Mai S; Feng S; Xiong G
Mol Oncol; 2022 Feb; 16(3):795-812. PubMed ID: 34821009
[TBL] [Abstract][Full Text] [Related]
9. Upregulation of CCT3 promotes cervical cancer progression through FN1.
Dou L; Zhang X
Mol Med Rep; 2021 Dec; 24(6):. PubMed ID: 34651664
[TBL] [Abstract][Full Text] [Related]
10. The New Biomarker for Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma (CESC) Based on Public Database Mining.
Ding H; Xiong XX; Fan GL; Yi YX; Chen YR; Wang JT; Zhang W
Biomed Res Int; 2020; 2020():5478574. PubMed ID: 32351997
[TBL] [Abstract][Full Text] [Related]
11. MIR205HG facilitates carcinogenesis of lung squamous cell carcinoma in vitro revealed by long noncoding RNA profiling.
Chang Y; Xue X; Li C; Zhao W; Ma Y; Xu F; Wu Z; Dai Y; Li Y; Liu Y; Chen L
Acta Biochim Biophys Sin (Shanghai); 2020 Apr; 52(4):371-381. PubMed ID: 32188965
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive analysis of ceRNA networks in HPV16- and HPV18-mediated cervical cancers reveals XIST as a pivotal competing endogenous RNA.
Berti FCB; Mathias C; Garcia LE; Gradia DF; de Araújo-Souza PS; Cipolla GA; de Oliveira JC; Malheiros D
Biochim Biophys Acta Mol Basis Dis; 2021 Oct; 1867(10):166172. PubMed ID: 34048924
[TBL] [Abstract][Full Text] [Related]
13. MIR31HG exhibits oncogenic property and acts as a sponge for miR-361-3p in cervical carcinoma.
Li Y
Biochem Biophys Res Commun; 2020 Sep; 529(4):890-897. PubMed ID: 32819595
[TBL] [Abstract][Full Text] [Related]
14. DGUOK-AS1 promotes cell proliferation in cervical cancer via acting as a ceRNA of miR-653-5p.
Wu N; Song H; Ren Y; Tao S; Li S
Cell Biochem Funct; 2020 Oct; 38(7):870-879. PubMed ID: 32283566
[TBL] [Abstract][Full Text] [Related]
15. LncRNA MIR205HG regulates melanomagenesis via the miR-299-3p/VEGFA axis.
Guo J; Gan Q; Gan C; Zhang X; Ma X; Dong M
Aging (Albany NY); 2021 Feb; 13(4):5297-5311. PubMed ID: 33535182
[TBL] [Abstract][Full Text] [Related]
16. Prediction of Prognosis and Chemotherapeutic Sensitivity Based on Cuproptosis-Associated lncRNAs in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma.
Zhou J; Xu L; Zhou H; Wang J; Xing X
Genes (Basel); 2023 Jun; 14(7):. PubMed ID: 37510286
[TBL] [Abstract][Full Text] [Related]
17. A novel prognostic signature based on cancer stemness and metabolism-related genes for cervical squamous cell carcinoma and endocervical adenocarcinoma.
Wang Y; Han Y; Jin L; Ji L; Liu Y; Lin M; Zhou S; Yang R
Aging (Albany NY); 2024 Apr; 16(8):7293-7310. PubMed ID: 38656879
[TBL] [Abstract][Full Text] [Related]
18. MLK4 as an immune marker and its correlation with immune infiltration in Cervical squamous cell carcinoma and endocervical adenocarcinoma(CESC).
Gong M; Shen F; Li Y; Ming L; Hong L
PLoS One; 2023; 18(8):e0290462. PubMed ID: 37594950
[TBL] [Abstract][Full Text] [Related]
19. A prognostic signature based on immune-related genes for cervical squamous cell carcinoma and endocervical adenocarcinoma.
Liu J; Wu Z; Wang Y; Nie S; Sun R; Yang J; Cheng W
Int Immunopharmacol; 2020 Nov; 88():106884. PubMed ID: 32795900
[TBL] [Abstract][Full Text] [Related]
20. Functional analysis of tumor-derived immunoglobulin lambda and its interacting proteins in cervical cancer.
Wang J; Huang J; Ding H; Ma J; Zhong H; Wang F; Chen Y; Peng H
BMC Cancer; 2023 Oct; 23(1):929. PubMed ID: 37784026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]